Financhill
Sell
6

PHAT Quote, Financials, Valuation and Earnings

Last price:
$4.09
Seasonality move :
17.73%
Day range:
$4.13 - $5.12
52-week range:
$4.07 - $19.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.86x
P/B ratio:
--
Volume:
937.7K
Avg. volume:
1.4M
1-year change:
-61.75%
Market cap:
$296M
Revenue:
$55.3M
EPS (TTM):
-$5.35

Earnings Data

Next earnings date for PHAT
May 09
2025
Most recent earnings per share
-$1.05
Beat by $0.03
(Mar 6/2025)
Consensus Estimate
-$1.08
(Mar 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHAT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $37.2M -- -- -$1.01 --
05/09/2025 Q1 $27.9M -- -- -$1.06 --
03/06/2025 Q4 $25.7M $29.7M -$1.05 -$1.08 $0.03
11/07/2024 Q3 $12.4M $16.4M -$1.32 -$1.47 $0.15
08/08/2024 Q2 $5.7M $7.3M -$1.56 -$1.24 -$0.32
05/09/2024 Q1 $2.1M $1.9M -$1.42 -$1.22 -$0.20
03/07/2024 Q4 $379.2K $682K -$1.45 -$1.00 -$0.45
11/09/2023 Q3 -- -- -$0.76 -$0.97 $0.21
08/10/2023 Q2 -- -- -$0.84 -$0.95 $0.11
05/10/2023 Q1 -- -- -$0.89 -$1.29 $0.40
02/28/2023 Q4 -- -- -$1.33 -$1.37 $0.04
11/08/2022 Q3 -- -- -$1.32 -$1.33 $0.01
08/02/2022 Q2 -- -- -$1.33 -$1.12 -$0.22
05/10/2022 Q1 -- -- -$1.07 -$1.02 -$0.05
03/01/2022 Q4 -- -- -$0.95 -$1.12 $0.17
11/08/2021 Q3 -- -- -$0.98 -$1.03 $0.05
08/10/2021 Q2 -- -- -$1.00 -$0.99 -$0.01
05/11/2021 Q1 -- -- -$0.96 -$1.32 $0.36
03/30/2021 Q4 -- -- -$1.58 -$1.12 -$0.46
11/10/2020 Q3 -- -- -$1.02 -- --
08/06/2020 Q2 -- -- -$0.64 -- --
05/12/2020 Q1 -- -- -$0.62 -- --
03/19/2020 Q4 -- -- -$3.96 -- --
11/25/2019 Q3 -- -- -$2.98 -- --

Phathom Pharmaceuticals Earnings Questions

  • How Much did Phathom Pharmaceuticals Generate in Revenue Last Quarter?

    Phathom Pharmaceuticals reported $29.7M worth of top line sales in its most recent quarter.

  • Did Phathom Pharmaceuticals Beat Earnings Last Quarter?

    Phathom Pharmaceuticals announced earnings per share of -$1.05 which represents a beat of analyst forecast a -$1.08 per share.

  • Is Phathom Pharmaceuticals Profitable?

    Phathom Pharmaceuticals reported $25.8M that represents $0.36 per share over the last quarter.

  • What is the Analyst Consensus for Phathom Pharmaceuticals EPS Next Year?

    Phathom Pharmaceuticals's earnings are forecast to decrease from -$5.29 per share to -$4.70 per share next year representing a decrease of -26.34%.

  • When is Phathom Pharmaceuticals's Earnings Date?

    Phathom Pharmaceuticals's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

How Bad Will the Stock Market Get?
How Bad Will the Stock Market Get?

In recent trading days, global stock markets have seen massive…

Is JOBY Stock a Buy, Sell or Hold?
Is JOBY Stock a Buy, Sell or Hold?

Joby Aviation (NYSE:JOBY) got started with the big idea of…

Stock Ideas

Sell
36
Is MSFT Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 30x

Sell
30
Is AAPL Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 28x

Sell
33
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 33x

Alerts

Buy
55
SLNO alert for Apr 9

Soleno Therapeutics [SLNO] is down 2.25% over the past day.

Sell
20
HELE alert for Apr 9

Helen Of Troy [HELE] is down 0.36% over the past day.

Sell
18
OXM alert for Apr 9

Oxford Industries [OXM] is up 2.95% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock